Amneal Pharmaceuticals, Inc. AMRX PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s PP&E (net)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported PP&E (net) of $444.61M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s PP&E (net) increased by 4.1% year-over-year, from $427.23M to $444.61M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s PP&E (net) has grown at a -1.5% compound annual growth rate (CAGR), from $477.75M to $442.95M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.